{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T15:30:03Z","timestamp":1764343803309,"version":"3.46.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We report the successful use of methotrexate (MTX) and rituximab in a Taiwanese patient with anti-signal recognition particle (SRP) antibody-positive immune-mediated necrotizing myopathy (IMNM) refractory to conventional therapy. The patient was a 72-year-old Taiwanese woman. She had facial erythema, bilateral thigh muscle pain, dysphagia, and an abnormally high creatine kinase level and was admitted to our hospital. She tested positive for anti-SRP antibodies, lung ground-glass opacities on computed tomography, and a high signal in the muscle on magnetic resonance imaging of the thigh. Muscle biopsy revealed an absence of inflammatory cell infiltration and prominent necrotic and regenerative tissues. High-dose glucocorticoids, tacrolimus, and intravenous immunoglobulins were administered. Although the creatine kinase levels were temporarily decreased, tacrolimus induced thrombotic microangiopathy. The patient also developed dysphagia and respiratory muscle weakness, which required temporary positive-pressure ventilation. Rituximab was administered on Days 63, 74, 81, and 88, and then MTX was initiated. Dysphagia and respiratory and limb muscle weakness gradually improved, enabling glucocorticoid dose reduction. By Day 200, her creatine kinase level had improved, and she was weaned off the ventilator. Herein, we report the case of a Taiwanese East Asian patient with anti-SRP antibody-positive IMNM who was refractory to conventional therapy and was successfully treated with MTX and rituximab.<\/jats:p>","DOI":"10.1093\/mrcr\/rxaf067","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:53:28Z","timestamp":1762606408000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful methotrexate and rituximab combination therapy for a Taiwanese patient with anti-signal recognition particle antibody-positive immune-mediated necrotizing myopathy: a case report"],"prefix":"10.1093","volume":"9","author":[{"given":"Haruka","family":"Toshina","sequence":"first","affiliation":[{"name":"Department of Dermatology, Wakayama Medical University , Wakayama ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2076-1603","authenticated-orcid":false,"given":"Shigeru","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Wakayama Medical University , Wakayama ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Matsumiya","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Wakayama Medical University , Wakayama ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Wakayama Medical University , Wakayama ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuta","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Department of Human Pathology, Wakayama Medical University , Wakayama ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuichi","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Wakayama Medical University , Wakayama ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Wakayama Medical University , Wakayama ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"2025112810272851000_ref1","first-page":"115","article-title":"Immune-mediated necrotizing myopathy","volume":"37","author":"Uruha","year":"2020","journal-title":"Shinkeichiryo (Neurol Ther)"},{"key":"2025112810272851000_ref2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies, Zandvoort, the Netherlands, 14\u201316 October 2016","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"2025112810272851000_ref3","doi-asserted-by":"crossref","first-page":"1756286421998918","DOI":"10.1177\/1756286421998918","article-title":"Rituximab in the treatment of immune mediated necrotizing myopathy: a review of case reports and case series","volume":"14","author":"Xiong","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"key":"2025112810272851000_ref4","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/acr.20219","article-title":"Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series","volume":"62","author":"Valiyil","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025112810272851000_ref5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2147\/JIR.S270114","article-title":"Immune-mediated necrotizing myopathy initially presenting as erythema nodosum","volume":"13","author":"Ying","year":"2020","journal-title":"J Inflamm Res"},{"key":"2025112810272851000_ref6","doi-asserted-by":"crossref","first-page":"777502","DOI":"10.3389\/fimmu.2021.777502","article-title":"Belimumab for immune-mediated necrotizing myopathy associated with anti-SRP antibodies: a case report and retrospective review of patients treated with anti-B-cell therapy in a single center and literature","volume":"12","author":"Cui","year":"2021","journal-title":"Front Immunol"},{"key":"2025112810272851000_ref7","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2025112810272851000_ref8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2169\/internalmedicine.49.2706","article-title":"Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998\u20132008","volume":"49","author":"Fujimura","year":"2010","journal-title":"Intern Med"},{"key":"2025112810272851000_ref9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11926-018-0763-z","article-title":"Potential pathogenic role of anti-signal recognition protein and anti-3-hydroxy-3-methylglutaryl-CoA reductase antibodies in immune-mediated necrotizing myopathies","volume":"20","author":"Ladislau","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"2025112810272851000_ref10","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1136\/jnnp-2016-313166","article-title":"Clinical features and prognosis in anti-SRP and anti-HMGCR necrotizing myopathy","volume":"87","author":"Watanabe","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2025112810272851000_ref11","doi-asserted-by":"crossref","first-page":"113936","DOI":"10.1016\/j.biopha.2022.113936","article-title":"The pathogenesis of anti-signal recognition particle necrotizing myopathy: a review","volume":"156","author":"Qiu","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"2025112810272851000_ref12","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/art.30344","article-title":"Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy","volume":"63","author":"Benveniste","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2025112810272851000_ref13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/ncpneuro0901","article-title":"B cells as therapeutic targets in autoimmune neurological disorders","volume":"4","author":"Dalakas","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"2025112810272851000_ref14","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1212\/01.wnl.0000313840.27060.bf","article-title":"Invited article: inhibition of B cell functions: implications for neurology","volume":"70","author":"Dalakas","year":"2008","journal-title":"Neurology"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxaf067\/65253103\/rxaf067.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/9\/2\/rxaf067\/65253103\/rxaf067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/9\/2\/rxaf067\/65253103\/rxaf067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T15:27:37Z","timestamp":1764343657000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/doi\/10.1093\/mrcr\/rxaf067\/8317961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,7,25]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxaf067","relation":{},"ISSN":["2472-5625"],"issn-type":[{"type":"electronic","value":"2472-5625"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"rxaf067"}}